Expression and Purification of the HIV Type 1 Rev Protein Produced inEscherichia coliand Its Use in the Generation of Monoclonal Antibodies
- 1 August 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 11 (8), 945-953
- https://doi.org/10.1089/aid.1995.11.945
Abstract
We have developed a simple and rapid procedure for the purification of large amounts of Rev protein overexpressed in E. coli. The purification method, which does not require denaturation of the protein, takes advantage of the positively charged nature of Rev and the ability of Rev to interact with nucleic acids. The purified protein was used to develop three novel murine monoclonal antibodies against Rev. Using fusion proteins between glutathione S-transferase (GST) and various fragments of the Rev protein, we mapped the specificity of these antibodies to different regions of the Rev protein. One antibody, 3H6, is directed against the nucleolar localization/RRE-binding domain of Rev between amino acids 38 and 44. Another antibody, 3G4, recognizes an epitope between amino acids 90 and 116 of Rev. A third antibody, 2G2, does not recognize any of the fusion proteins, and may be directed against a conformational epitope. All three antibodies are able to detect Rev on Western blots and to immunoprecipitate Rev under native conditions. However, only 3H6 and 3G4 immunoprecipitate Rev under denaturing conditions and are able to detect Rev expressed in transfected cells by indirect immunofluorescence. These antibodies should prove useful in further studies of Rev function.Keywords
This publication has 65 references indexed in Scilit:
- HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational propertiesBiochemistry, 1991
- Circular dichroism studies of the HIV-1 Rev protein and its specific RNA binding siteBiochemistry, 1990
- Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action.Genes & Development, 1990
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- The pAS vector system and its application to heterologous gene expression in escherichia coliHepatology, 1987
- Efficient Expression of Heterologous Genes in Escherichia coliAnnals of the New York Academy of Sciences, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985
- Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluationArthritis & Rheumatism, 1982